Bernard Esquivel, M.D., Ph.D., MHA
- Researcher, Clinical Pharmacogenetics Implementation Consortium (CPIC)
- President, Latin American Association for Personalized Medicine
Bernard Esquivel, M.D., Ph.D., MHA is a specialist in Clinical Immunology and Allergies certified by the American College of Allergy, Asthma and Immunology (ACAAI), as well as the European Academy of Allergy and Clinical Immunology (EAACI). He received his medical training at the National Autonomous University of Mexico (UNAM), followed by a Masters in Medical Genetics from the University of Valencia (Spain) and a Masters in Health Administration. He cofounded and has served as president of the Latin American Personalized Medicine Association (ALAMP) since 2014. He established the first integral genetic services company in Mexico: Total Quality Medicine and in 2016 opened the first precision medicine clinic in Mexico, Genomedik. He is an active researcher with the Clinical Pharmacogenetics Implementation Consortium (CPIC) and editor/reviewer of Personalized Medicine Journal.
CME Disclosure: OneOme, Mayo Clinic: Previous Honoraria, Advisory Board, Teaching